ArticleBMJ paediatrics open2026
Improving management of acute asthma in children through an integrated care pathway.
Article in BMJ paediatrics open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo evaluate the impact of an asthma integrated care pathway (AICP) on adherence to evidence-based practices in the management of paediatric acute asthma (AA) across primary care (PC) and paediatric emergency department (PED) settings.
methodsWe conducted a 2-year quality improvement initiative (May 2023-April 2025) in two health districts and a regional PED in Spain. The AICP was developed using a design-thinking approach and included input from families and clinicians. Interventions included training, electronic decision support, family education and regular audit and feedback. The primary outcome was the proportion of AA cases treated with bronchodilator via metered-dose inhaler (MDI) with holding chamber. Secondary outcomes included documentation of severity (Pulmonary Score) and symptom control assessment (Paediatric Asthma Control Tool). Interrupted time series analyses (ITSA) were carried out.
resultsA total of 7241 AA episodes were recorded (4150 PED, 3091 PC). MDI with holding chamber use increased from 9.0% to 26.7% in PC and from 31.5% to 61.4% in PED. Pulmonary Score documentation improved from 16.3% to 45.1% in PC and from 48.4% to 78.7% in PED. Persistent symptom assessment increased from 8.0% to 23.4% and from 32.9% to 67.4% in the PC centres and the PED, respectively. ITSA showed differential patterns of change between PC and PED. No changes were observed in PED length of stay, hospitalisation or revisit rates.
conclusionsImplementation of a structured, codesigned AICP significantly improved adherence to recommended asthma care practices. Integrated pathways can effectively bridge the gap between guidelines and practice in paediatric asthma care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.